Department of Tumor Pathology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194, Japan.
Department of Oral Maxillofacial Surgery, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
Int J Clin Oncol. 2020 Sep;25(9):1563-1569. doi: 10.1007/s10147-020-01735-5. Epub 2020 Jul 12.
DEK is a highly conserved nuclear factor that plays an important role in the regulation of multiple cellular processes. DEK was discovered to be an oncogene as a fusion with NUP214 gene, which results in producing DEK-NUP214 proteins, in a subset of patients with acute myeloid leukemia. Subsequently, DEK overexpression was reported in many cancers, thus DEK itself is considered to be an oncoprotein. DEK has been reported to play important roles in the progression of early and late stage squamous cell carcinoma (SCC) and is useful for early diagnosis of the disease. These findings have made DEK an attractive therapeutic target, especially for human papillomavirus (HPV)-associated SCC. However, the mechanism of DEK in SCC remains unclear. In this review, we discuss human DEK oncogene-related SCC.
DEK 是一种高度保守的核因子,在调节多种细胞过程中发挥重要作用。DEK 最初被发现是一种癌基因,它与 NUP214 基因融合,导致产生 DEK-NUP214 蛋白,在一部分急性髓系白血病患者中发现。随后,在许多癌症中报道了 DEK 的过度表达,因此 DEK 本身被认为是一种癌蛋白。已有报道称 DEK 在早期和晚期鳞状细胞癌 (SCC) 的进展中发挥重要作用,并且对疾病的早期诊断有用。这些发现使 DEK 成为一个有吸引力的治疗靶点,特别是对于人乳头瘤病毒 (HPV) 相关 SCC。然而,DEK 在 SCC 中的作用机制尚不清楚。在这篇综述中,我们讨论了人类 DEK 癌基因相关 SCC。